Sage Journals: Discover world-class research

Open access

Review article

First published 2018

Prolonged-release fampridine in multiple sclerosis: clinical data and real-world experience. Report of an expert meeting

Philipp Albrecht, Ingrid Kristine Bjørnå, David Brassat [...]

Therapeutic Advances in Neurological Disorders

Open access

Case report

First published 2022

Prolonged-release fampridine for the treatment of myoclonus after cervical myelitis: a case report

Mona Klara Ros Müller, Monika Christ, Markus Naumann [...]

Therapeutic Advances in Neurological Disorders

Open access

Research article

First published 2016-2

Prolonged-release fampridine and walking and balance in MS: randomised controlled MOBILE trial

Raymond Hupperts, Jan Lycke, Christine Short [...]

Multiple Sclerosis Journal

Retricted access

Research article

First published 2016-10

Prolonged-release fampridine in multiple sclerosis: Improved ambulation effected by changes in walking pattern

Björn Zörner, Linard Filli, Katja Reuter [...]

Multiple Sclerosis Journal

Open access

Research article

First published 2018

Combined walking outcome measures identify clinically meaningful response to prolonged-release fampridine

Núria Sola-Valls, Yolanda Blanco, María Sepúlveda [...]

Therapeutic Advances in Neurological Disorders

Open access

Research article

First published 2022

Efficacy of prolonged-release fampridine versus placebo on walking ability,dynamic and static balance,physical impact of multiple sclerosis,and quality of life: an integrated analysis of MOBILE and ENHANCE

Raymond Hupperts, Claudio Gasperini, Jan Lycke [...]

Therapeutic Advances in Neurological Disorders

Open access

Research article

First published 2018-1

Prolonged-Release Fampridine as Adjunct Therapy to Active Motor Training in MS Patients: A Pilot,Double-Blind,Randomized,Placebo-Controlled Study

François Jacques, Adrian Schembri, Avi Nativ [...]

Multiple Sclerosis Journal – Experimental,Translational and Clinical

Retricted access

Research article

First published 2016-6

Improved patient-reported health impact of multiple sclerosis: The ENABLE study of PR-fampridine

Richard Macdonell, Guy Nagels, David-Axel Laplaud [...]

Multiple Sclerosis Journal

Open access

Research article

First published 2015-9

Long-term safety and efficacy of dalfampridine for walking impairment in patients with multiple sclerosis: Results of open-label extensions of two Phase 3 clinical trials

Andrew D Goodman, Francois Bethoux, Theodore R Brown [...]

Multiple Sclerosis Journal

Search results